FDA approves HIV treatment, SYMTUZA
by Press Release from Outbreak News Today on (#3V53N)
The Janssen Pharmaceutical Companies of Johnson & Johnson announced the U.S. Food and Drug Administration (FDA) has approved SYMTUZAa, the first and only complete, darunavir-based single-tablet regimen (STR) for the treatment of human immunodeficiency virus type 1 (HIV-1) in treatment-naive and certain virologically suppressed adults. SYMTUZAa combines the proven high barrier to resistance of darunavir with ["]
The post FDA approves HIV treatment, SYMTUZA appeared first on Outbreak News Today.